首页> 美国卫生研究院文献>Journal of Breast Cancer >D2-40 Podoplanin and CD31 as a Prognostic Predictor in Invasive Ductal Carcinomas of the Breast
【2h】

D2-40 Podoplanin and CD31 as a Prognostic Predictor in Invasive Ductal Carcinomas of the Breast

机译:D2-40Podoplanin和CD31作为乳腺浸润性导管癌的预后指标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeDistant metastasis and recurrence are major prognostic factors associated with breast cancer. Both lymphovascular invasion (LVI) and blood vessel invasion (BVI) are important routes for metastasis to regional lymph nodes and for systemic metastasis. Despite the importance of vascular invasion as a prognostic factor, application of vascular invasion as a histopathological criterion is controversial. The aim of this study was to distinguish LVI from BVI in prognosis and recurrence of breast cancer using an endothelial subtype specific immunohistochemical stain (podoplanin, D2-40, and CD31).
机译:目的远处转移和复发是与乳腺癌相关的主要预后因素。淋巴管浸润(LVI)和血管浸润(BVI)都是转移到区域淋巴结和全身转移的重要途径。尽管将血管浸润作为预后因素很重要,但将血管浸润作为组织病理学标准还是有争议的。这项研究的目的是通过使用内皮亚型特异性免疫组织化学染色剂(podoplanin,D2-40和CD31)在乳腺癌的预后和复发中区分LVI和BVI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号